Hospice care is a specialized type of healthcare that focuses on providing holistic, compassionate care for individuals facing a life-limiting illness. It’s delivered by an interdisciplinary team, typically under the guidance of a physician specializing in hospice and palliative medicine. The core principle of hospice is to enhance the quality of life for patients and their families during the end-of-life journey, offering comfort and comprehensive symptom management for those with a prognosis of six months or less.
Determining eligibility for hospice involves a thorough assessment of a patient’s overall health status, considering all existing conditions and their impact on prognosis. While many conditions could potentially qualify a patient for hospice, some chronic conditions may be stable and not significantly impact the terminal prognosis. Conversely, aggressive treatments for certain conditions might become burdensome or non-palliative in the terminal phase. Therefore, a comprehensive evaluation is crucial to identify hospice-appropriate diagnoses and develop a care plan that aligns with the patient’s needs and wishes.
Research consistently demonstrates that hospice care significantly improves the quality of life for patients facing terminal illness. However, studies also reveal a concerning trend: patients often enroll in hospice care much later than they are eligible. On average, hospice patients live only about 2.5 months after enrollment, despite having an initial prognosis of six months or less. This statistic highlights a critical issue – delayed access to hospice services. Patients who could benefit from hospice for months are missing out on crucial support and care due to late referrals. Understanding and addressing the reasons for this delay is vital to ensure that individuals receive the full spectrum of benefits hospice offers.
The process of enrolling in hospice care is not solely based on a physician’s prognosis. It requires a detailed and meticulous assessment to ensure that patients meet the necessary criteria. The guidelines and regulations surrounding hospice diagnoses are continually evolving, with updates from organizations like the Centers for Medicare and Medicaid Services (CMS) impacting billing, coding, and eligibility interpretations. Navigating these complexities can be challenging for healthcare providers who are not specialized in hospice care.
Hospice organizations and physicians specializing in palliative care play a crucial role in providing guidance and support in determining hospice eligibility. They offer expertise in assessing complex cases, understanding evolving guidelines, and facilitating conversations with patients and families about the benefits of hospice. Early referral to hospice, soon after a terminal diagnosis is made, is encouraged to ensure seamless integration of comprehensive end-of-life care. Ultimately, hospice agencies bear the responsibility of ensuring that all patients under their care meet the eligibility criteria and that the services provided are medically necessary and aligned with patient needs.
Understanding Hospice-Appropriate Diagnoses
CMS has refined its approach to hospice diagnoses, moving beyond a singular primary diagnosis to encompass all relevant conditions that influence prognosis or contribute to the terminal condition. The principal diagnosis in hospice is defined as the condition primarily responsible for the patient’s terminal prognosis and need for hospice care. This diagnosis is considered the major factor contributing to a life expectancy of six months or less. In cases where multiple hospice-appropriate diagnoses equally contribute to the prognosis, all should be documented as principal diagnoses.
It’s important to recognize that diagnoses in hospice care are dynamic. As a patient’s illness progresses, diagnoses may change, requiring ongoing documentation, additions, and revisions. Static diagnoses over time might inaccurately suggest stability, potentially leading to questions about continued hospice eligibility. Therefore, regular re-evaluation and documentation of all relevant diagnoses are essential to accurately reflect the patient’s evolving condition.
Determining a patient’s terminal prognosis, which is central to hospice eligibility, often involves considering multiple hospice-appropriate diagnoses. All diagnoses contributing to the prognosis must be confirmed and documented by a physician or authorized provider who assumes legal responsibility for establishing the patient’s diagnoses. This comprehensive diagnostic approach ensures that hospice care is appropriately targeted to those who truly need it.
Key Concerns in Hospice Diagnosis and Eligibility
Several areas of concern frequently arise regarding hospice-appropriate diagnoses, primarily centered around ensuring approval, proper billing, and accurate coding. Common challenges include the effective use of symptom codes, combination codes, and correctly coding diagnoses that may not be explicitly listed in standard manuals. Recent areas of focus also involve specific diagnoses such as dementia, where ambiguities can arise in determining hospice eligibility. Other concerns include establishing fractures as primary diagnoses, accurately sequencing primary versus secondary neoplasms, and distinguishing between acute and late effects in cerebrovascular diagnoses coding. Addressing these concerns requires ongoing education and vigilance in applying evolving guidelines and coding practices.
Clinical Significance of Accurate Hospice Diagnosis
Each hospice patient is unique, and their care plan must reflect their individual circumstances. Numerous diagnoses and conditions can influence care during the final stages of life. Comprehensive, clear, and factual documentation is paramount, accurately depicting the patient’s condition and the impact of their diagnoses on their prognosis. Regular re-evaluation of a patient’s continued hospice eligibility is crucial, considering their physical, mental, social, and spiritual needs. CMS mandates the coding of all current diagnoses in patient documentation. Consequently, historical diagnoses that no longer affect the patient’s current status or prognosis (history codes) should be removed in accordance with coding guidelines. Hospice claims can accommodate up to twenty-five diagnoses. If certain conditions lack specific codes or cannot be included in the diagnoses section, they can be addressed within the narrative section of the patient’s plan of care documentation. The process of hospice enrollment and diagnosis determination demands critical thinking from physicians, involving maintaining an updated list of conditions and removing irrelevant history codes when appropriate.
For practical guidance, the following is an abridged version of CMS’s assessment criteria for disease progression and non-disease baseline guidelines:
Part 1: Guidelines for Decline in Clinical Status
A. Progression of Disease: Evidenced by worsening status, symptoms, signs, and laboratory results:
* **Clinical Status:** Recurrent or refractory infections; progressive inanition (e.g., weight loss ≥10%, decreased albumin, dysphagia with aspiration).
* **Symptoms:** Nausea/vomiting, dyspnea, persistent cough, fatigue, cognitive decline, diarrhea, progressive pain.
* **Signs:** Hypotension, edema, ascites, progressive weakness, new altered mental status.
* **Laboratory Results:** Worsening pCO2/pO2/SaO2, liver function tests, tumor markers, unstable sodium/potassium levels.B. Progressive disease leading to decline in Karnofsky Performance Status (KPS) or Palliative Performance Scale (PPS).
C. Worsening functional assessment staging in diagnosed dementia.
D. Increased need for assistance with Activities of Daily Living (ADLs).
E. Development or worsening of refractory Stage 3 or 4 pressure ulcers despite optimal wound care.
F. Increased healthcare utilization (ER visits, hospitalizations, physician appointments) related to the primary hospice diagnosis prior to hospice enrollment.
Part 2: Non-Disease Specific Baseline Guidelines (Both A and B must be met)
A. Physiological impairment of functional status: KPS or PPS < 70%.
B. Requires assistance with ≥2 ADLs: ambulation, transfer, dressing, feeding, continence, bathing.
C. Comorbidities: Presence of significant diseases contributing to a prognosis of ≤6 months, even if not the primary hospice diagnosis, including:
* Chronic Obstructive Pulmonary Disease (COPD)
* Congestive Heart Failure (CHF)
* Ischemic Heart Disease
* Diabetes Mellitus
* Neurologic Diseases (Cerebrovascular Accident, Parkinson's Disease, Multiple Sclerosis, Amyotrophic Lateral Sclerosis)
* Renal Failure
* Liver Disease
* Neoplasia
* Acquired Immunodeficiency Syndrome/HIV
* Dementia
* Refractory Severe Autoimmune Diseases (e.g., Lupus, Rheumatoid Arthritis)
* Recurrent SepsisConclusion
Accurate Diagnosis For Hospice eligibility is a multifaceted process that extends beyond a simple prognosis. It requires a comprehensive understanding of the patient’s overall health, meticulous documentation, and adherence to evolving CMS guidelines. Hospice organizations and palliative care specialists play a vital role in navigating these complexities, ensuring that patients receive timely access to the comprehensive and compassionate care that hospice provides. By prioritizing accurate diagnosis and early referral, we can ensure that more individuals benefit from the improved quality of life and dignified end-of-life care that hospice offers.
References
- Buss MK, Rock LK, McCarthy EP. Understanding Palliative Care and Hospice: A Review for Primary Care Providers. Mayo Clin Proc. 2017 Feb;92(2):280-286. [PubMed: 28160875]
- Wallace CL. Examining hospice enrollment through a novel lens: Decision time. Palliat Support Care. 2017 Apr;15(2):168-175. [PubMed: 27407060]
- Wang X, Knight LS, Evans A, Wang J, Smith TJ. Variations Among Physicians in Hospice Referrals of Patients With Advanced Cancer. J Oncol Pract. 2017 May;13(5):e496-e504. [PMC free article: PMC5455161] [PubMed: 28221897]
- Cheraghlou S, Gahbauer EA, Leo-Summers L, Stabenau HF, Chaudhry SI, Gill TM. Restricting Symptoms Before and After Admission to Hospice. Am J Med. 2016 Jul;129(7):754.e7-754.e15. [PMC free article: PMC4914433] [PubMed: 26968471]
- Dolin R, Hanson LC, Rosenblum SF, Stearns SC, Holmes GM, Silberman P. Factors Driving Live Discharge From Hospice: Provider Perspectives. J Pain Symptom Manage. 2017 Jun;53(6):1050-1056. [PubMed: 28323079]
- Cherlin EJ, Brewster AL, Curry LA, Canavan ME, Hurzeler R, Bradley EH. Interventions for Reducing Hospital Readmission Rates: The Role of Hospice and Palliative Care. Am J Hosp Palliat Care. 2017 Sep;34(8):748-753. [PubMed: 27443281]
- Mehta A, Chai E, Berglund K, Rizzo E, Moreno J, Gelfman LP. Using Admission Karnofsky Performance Status as a Guide for Palliative Care Discharge Needs. J Palliat Med. 2021 Jun;24(6):910-913. [PMC free article: PMC8336248] [PubMed: 33524302]
- Jones BW. Evidence-based practice in hospice: is qualitative more appropriate than quantitative? Home Healthc Nurse. 2013 Apr;31(4):184-8. [PubMed: 23549249]
- Kaufman BG, Klemish D, Kassner CT, Reiter JP, Li F, Harker M, O’Brien EC, Taylor DH, Bhavsar NA. Predicting Length of Hospice Stay: An Application of Quantile Regression. J Palliat Med. 2018 Aug;21(8):1131-1136. [PubMed: 29762075]
- Goy ER, Bohlig A, Carter J, Ganzini L. Identifying predictors of hospice eligibility in patients with Parkinson disease. Am J Hosp Palliat Care. 2015 Feb;32(1):29-33. [PubMed: 23975684]
- Wladkowski SP, Wallace CL. Current Practices of Live Discharge from Hospice: Social Work Perspectives. Health Soc Work. 2019 Feb 01;44(1):30-38. [PubMed: 30561640]
Disclosure: Dac Teoli declares no relevant financial relationships with ineligible companies.
Disclosure: Abhishek Bhardwaj declares no relevant financial relationships with ineligible companies.
